Advance Program | ADA 82nd Scientific Sessions - 20

ADVANCE PROGRAM
* Translational Science to Promote
Health Equity and Address Social
Determinants of Health in Diabetes
Prevention and Care
The Next Generation of Diabetes
Translation-A Path to Health Equity
Debra Haire-Joshu, PhD
Bridging the Gap-Addressing
Structural and Social Inequities in
Diabetes Care
Kathryn E. Gunter, MPH, MSW
Translational Interventions for
Type 2 Diabetes Management Among
Underserved Hispanics/Latinos
Gregory A. Talavera, MD, MPH
Peer Support to Enhance Type 2
Diabetes Prevention among African
American and Latino Adults
Luis A. Rodriguez, PhD, MPH, RD
Translational Interventions and
Implementation Science to Address
Disparities in Ethnic Minority Youth with
Type 1 Diabetes
Deborah A. Ellis, PhD
* New Strategies for Insulin use in
Type 2 Diabetes
Overcoming Inertia-Using Continuous
Glucose Monitoring to Facilitate
Effective Insulin Titration in People with
Type 2 Diabetes on Basal-Insulin or
Basal-Bolus Insulin Regimens
Thomas W. Martens, MD
What GRADE did Insulin Therapy
Achieve? Lessons on Effective Insulin
Management from the GRADE Study
Connected-Insulin Pen Systems
Provide Critical Data to Guide Effective
Insulin Therapy-Clinical Trial and
Real-World Evidence, in Type 1 and
Type 2 Diabetes
Viral Shah, MD
Automated Insulin Delivery May Be
the Best Hope for Optimal Insulin
Management in T2D-Clinical Trial
Evidence
Georgia M. Davis, MD
* Heterogeneity of Diabetes-
Underlying Mechanisms,
Epidemiology, and Intervention
Response
Pathophysiology-Based Subgrouping in
Diabetes and Prediabetes
Robert Wagner, MD
Heterogeneity in the Pathogenesis
and Underlying Mechanisms of Type 2
Diabetes
Differential Intervention and Treatment
Effects in Type 2 Diabetes Trials-
Implications for Disease Pathogenesis
and Management
Kristina Utzschneider, MD
Question and Discussion Period
* Innate Immunity in Diabetes
Lymphocyte Trafficking into Diabetic
Islets
Rachel S. Friedman, PhD
Epithelial Cells and Altered Innate
Immunity in Diabetes
Shannon Wallet, PhD
The Intersection of Innate and Adaptive
Immunity in Type 1 Diabetes
Jon D. Piganelli, PhD
Modulating Innate Immunity to Treat
Diabetes
Bruce Verchere, PhD
* Micropeptides and Signaling
Regulation of Endoplasmic Reticulum
Stress by Microproteins
Alan Saghatelian, PhD
Microproteins Regulation of
Mitochondrial Function
Ryan Boudreau, PhD
MOTS-c Coordinates Mitoribosomal
Stress during Exercise
Changhan David Lee, PhD
Uncovering Micropeptides in
Inflammation and Metabolism
Ling Yang, PhD
* Oral Presentations
4:15 p.m.-6:15 p.m.
* Suicide and Self-Injury-Unveiling
and Addressing the Hidden
Nightmare in Diabetes
Assessing Depression, Suicide, and
Self-Harm-What Can We Do in
Routine Diabetes Care?
Depression, Suicidal Ideation, and SelfHarm
among Adults with Diabetes-
Unmet Needs and How to Address
Them
Katharine Barnard, PhD
Educational Support Needs for
Addressing Suicide and Self-Harm in
Diabetes
Shideh Majidi, MD
The RESCUE Collaborative Community
on Suicide and Self-Harm in Diabetes
Yiduo Wu, PhD
Partnership among RESCUE,
Advocacy, and Industry to Address
Suicide and Self-Harm in Diabetes
Kelly L. Close, MBA
* Clinical Pearls in the Practical use of
Automated Insulin Delivery Systems
Differences in Closed Loop
Algorithms-Benefits and
Limitations
Boris Kovatchev, PhD
Practical Approaches to Insulin Dose
Adjustments while on Closed Loop
David M. Maahs, MD, PhD
Strategies to Effectively Prevent
Exercise-Induced Dysglycemia while on
Closed Loop
Laurel H. Messer, PhD, RN, CDCES
Should I Eat That Burger and
Fries? How to Tackle Postprandial
Hyperglycemia Associated with HighProtein
and High-Fat Meals
Stuart A. Weinzimer, MD
HYBRID | NEW ORLEANS | JUNE 3-7, 2022 | #ADA2022
20
Advance Program | ADA 82nd Scientific Sessions

Table of Contents for the Digital Edition of Advance Program | ADA 82nd Scientific Sessions
